Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Appointed director
CC transcript
Inv. presentation
Director departure
|
|
INTERPACE BIOSCIENCES, INC. (IDXG)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2021 |
4
| Burnell Thomas W. (President & CEO) has filed a Form 4 on INTERPACE BIOSCIENCES, INC.|
Txns:
| Bought 10,855 shares
@ $8.68, valued at
$94.2k
|
|
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| Kamin Peter (10% Owner) has filed a Form 4 on INTERPACE BIOSCIENCES, INC.|
Txns:
| Bought 14,946 shares
@ $3.17, valued at
$47.4k
Bought 16,360 shares
@ $3.08, valued at
$50.4k
Bought 14,874 shares
@ $3.17, valued at
$47.2k
Bought 14,726 shares
@ $3.08, valued at
$45.4k
Bought 8,333 shares
@ $3.17, valued at
$26.4k
Bought 8,252 shares
@ $3.08, valued at
$25.4k
Bought 2,897 shares
@ $3.17, valued at
$9.2k
Bought 2,862 shares
@ $3.08, valued at
$8.8k
|
|
| 02/02/2021 |
4
| Gorman Robert J. (Director) has filed a Form 4 on INTERPACE BIOSCIENCES, INC.|
Txns:
| Granted 12,438 shares
@ $4.02, valued at
$50k
|
|
| 12/02/2020 |
4
| STOVER JACK E (Former officer and director) has filed a Form 4 on INTERPACE BIOSCIENCES, INC.|
Txns:
| Granted 43,750 options to buy
@ $6, valued at
$262.5k
|
|
| 12/02/2020 |
4
| Burnell Thomas W. (President and CEO) has filed a Form 4 on INTERPACE BIOSCIENCES, INC.|
Txns:
| Granted 100,000 shares
@ $0
Granted 125,000 shares
@ $0 |
|
| 07/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/06/2020 |
4
| STOVER JACK E (President and CEO) has filed a Form 4 on INTERPACE BIOSCIENCES, INC.|
Txns:
| Granted 7,188 shares
@ $0 |
|
| 02/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2020 |
4
| Knechtel Fred S. (CFO) has filed a Form 4 on INTERPACE BIOSCIENCES, INC.|
Txns:
| Granted 60,000 options to buy
@ $7.91, valued at
$474.6k
|
|
| 01/31/2020 |
4
| Gorman Robert J. (Director) has filed a Form 4 on INTERPACE BIOSCIENCES, INC.|
Txns:
| Granted 6,321 shares
@ $7.91, valued at
$50k
|
|
| 01/31/2020 |
4
| Early James (CFO) has filed a Form 4 on INTERPACE BIOSCIENCES, INC.|
Txns:
| Granted 5,000 restricted stock units
@ $0 |
|
| 01/24/2020 |
4
| STOVER JACK E (President and CEO) has filed a Form 4 on INTERPACE BIOSCIENCES, INC.|
Txns:
| Granted 35,000 options to buy
@ $8.18, valued at
$286.3k
|
|
| 01/24/2020 |
4
| Richard Gregory (Chief Commerical Officer) has filed a Form 4 on INTERPACE BIOSCIENCES, INC.|
Txns:
| Granted 7,500 options to buy
@ $8.18, valued at
$61.4k
|
|
| 01/17/2020 |
4
| McCarthy Laurence (Director) has filed a Form 4 on INTERPACE BIOSCIENCES, INC.|
Txns:
| Disposed/sold 270 convertible preferred
@ $0
Granted 27,000 convertible preferred
@ $0
Granted 1,000 convertible preferred
@ $1000, valued at
$1M
|
|
| 01/17/2020 |
4
| Lev Eric B. (Director) has filed a Form 4 on INTERPACE BIOSCIENCES, INC.|
Txns:
| Disposed/sold 270 convertible preferred
@ $0
Granted 27,000 convertible preferred
@ $0
Granted 1,000 convertible preferred
@ $1000, valued at
$1M
|
|
| 01/17/2020 |
4
| Ampersand 2018 Limited Partnership (10% Owner) has filed a Form 4 on INTERPACE BIOSCIENCES, INC.|
Txns:
| Disposed/sold 270 convertible preferred
@ $0
Granted 27,000 convertible preferred
@ $0
Granted 1,000 convertible preferred
@ $1000, valued at
$1M
|
|
| 10/18/2019 |
4
| Lev Eric B. (Director) has filed a Form 4 on Interpace Diagnostics Group, Inc.|
Txns:
| Granted 130 convertible preferred
@ $100000, valued at
$13M
|
|
| 10/18/2019 |
4
| Ampersand 2018 Limited Partnership (10% Owner) has filed a Form 4 on Interpace Diagnostics Group, Inc.|
Txns:
| Granted 130 convertible preferred
@ $100000, valued at
$13M
|
|
| 10/15/2019 |
4
| Lev Eric B. (Director) has filed a Form 4 on Interpace Diagnostics Group, Inc.|
Txns:
| Granted 80 convertible preferred
@ $0
Disposed/sold 80 convertible preferred
@ $0 |
|
| 10/15/2019 |
4
| Ampersand 2018 Limited Partnership (10% Owner) has filed a Form 4 on Interpace Diagnostics Group, Inc.|
Txns:
| Granted 80 convertible preferred
@ $0
Disposed/sold 80 convertible preferred
@ $0 |
|
| 03/15/2019 |
4
| Freeburg Thomas John (Chief Accounting Officer) has filed a Form 4 on Interpace Diagnostics Group, Inc.|
Txns:
| Granted 2,000 shares
@ $0
Granted 8,000 options to buy
@ $0.98, valued at
$7.8k
|
|
| 03/15/2019 |
4
| STOVER JACK E (President and CEO) has filed a Form 4 on Interpace Diagnostics Group, Inc.|
Txns:
| Granted 86,922 shares
@ $0
Granted 347,688 options to buy
@ $0.98, valued at
$340.7k
|
|
| 03/15/2019 |
4
| Richard Gregory (Chief Commerical Officer) has filed a Form 4 on Interpace Diagnostics Group, Inc.|
Txns:
| Granted 39,528 shares
@ $0
Granted 158,112 options to buy
@ $0.98, valued at
$154.9k
|
|
| 03/15/2019 |
4
| Early James (CFO) has filed a Form 4 on Interpace Diagnostics Group, Inc.|
Txns:
| Granted 26,340 shares
@ $0
Granted 105,360 options to buy
@ $0.98, valued at
$103.3k
|
|
| 12/06/2018 |
4
| Early James (CFO) has filed a Form 4 on Interpace Diagnostics Group, Inc.|
Txns:
| Granted 15,000 options to buy
@ $1.08, valued at
$16.2k
|
|
| 12/06/2018 |
4
| Richard Gregory (Chief Commerical Officer) has filed a Form 4 on Interpace Diagnostics Group, Inc.|
Txns:
| Granted 67,000 options to buy
@ $1.08, valued at
$72.4k
|
|
|
|
|